Psychiatrist Indicted For Fraud In Paxil Trials - Faces a Maximum Prison Sentence of 445 years, and 10 Million Dollar Fine

From WDSU in Louisiana

Dr. Maria Carmen Palazzo has been indicted by a federal grand jury on 55 counts of health care fraud and false documentation in connection with a clinical trial of Paxil in children and adolescents.

U.S. Attorney Jim Letten said the indictment alleges that during approximately a five-year period, the 55-year-old Palazzo defrauded Medicare in connection with services she claimed to have rendered to patients in a Psychiatric Partial Hospitalization Program at Touro Infirmary.

The indictment also charges that Palazzo defrauded Medicare by submitting fraudulent invoices to Touro for consulting and medical director services. The indictment said because of that Medicare paid Palazzo over $653,000 she was not entitled to receive.

Palazzo, who specializes in psychiatry, is also charged with offenses relating to clinical trials involving Paxil.

According to the indictment, Palazzo, as a clinical investigator for SmithKline Beecham doing business as GlaxoSmithKline, fraudulently failed to maintain and prepare records required by the FDA for evaluation the drug's safety and effectiveness in children and adolescents.

If convicted, Letten said Palazzo faces a maximum term of 445 years, and a fine of $10.15 million.

See also the US Attorney office for future press releases